Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Lataukset:

Motzer, Robert J.

Tannir, Nizar M.

McDermott, David F.

Arén Frontera, Osvaldo

Melichar, Bohuslav

Choueiri, Toni K.

Plimack, Elizabeth R.

Barthélémy, Philippe

Porta, Camillo

George, Saby

Powles, Thomas

Donskov, Frede

Neiman, Victoria

Kollmannsberger, Christian K.

Salman, Pamela

Gurney, Howard

Hawkins, Robert

Ravaud, Alain

Grimm, Marc-Oliver

Bracarda, Sergio

Barrios, Carlos H.

Tomita, Yoshihiko

Castellano, Daniel

Rini, Brian I.

Chen, Allen C.

Mekan, Sabeen

McHenry, M. Brent

Wind-Rotolo, Megan

Doan, Justin

Sharma, Padmanee

Hammers, Hans J.

Escudier, Bernard

Kellokumpu-Lehtinen, Pirkko-Liisa

for the CheckMate 214 Investigators

2018

New England Journal of Medicine 378 14
1277-1290
Lääketieteen ja biotieteiden tiedekunta - Faculty of Medicine and Life Sciences

This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.